他汀类药物治疗冠心病抗炎机制的研究进展

被引：18

作者：

赵立坤 ^{[1
]}

葛长江 ^{[2
]}

吕树铮 ^{[2
]}

机构：

[1] 中国航天科工集团医院心内科

[2] 首都医科大学附属北京安贞医院心内科

来源：

中国现代医药杂志 | 2009年 / 11卷 / 10期

关键词：

他汀类; LDL; 冠心病患者; 抗炎机制; 血清胱抑素; 阿托伐他汀; 药物治疗; 斑块破裂; 动脉粥样硬化; 动脉硬化; 心绞痛; 冠心病; 稳定斑块; 研究进展;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

1002 ; 100201 ;

摘要：

<正>冠状动脉内易损粥样斑块破裂、继发血栓形成是急性冠脉综合征的发生机制,而炎症反应是导致冠脉内结构性易损斑块向功能性易损斑块进展的重要环节,临床实验和基础研究表明:他汀类药物不但具有降低血浆胆固醇的主要作用,而且还涉及不依赖于其降血脂特性的非调脂抗动脉粥样硬化作用如抗炎性反应、促进斑块稳定及抑制血小板聚集、抑

引用

页码：123 / 125

页数：3

共 7 条

[1]

Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study[J] . Joachim H. Ix,Michael G. Shlipak,Glenn M. Chertow,Mary A. Whooley.Circulation . 2007 (2)

[2]

Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease （from the REVERSAL Study）[J] . Stephen J. Nicholls,E. Murat Tuzcu,Ilke Sipahi,Paul Schoenhagen,Stanley L. Hazen,Fady Ntanios,Chuan-Chuan Wun,Steven E. Nissen.The American Journal of Cardiology . 2006 (11)

[3] Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction [J].

Kodama, Yasushi ;

Kitta, Yoshinobu ;

Nakamura, Takamitsu ;

Takano, Hajime ;

Umetani, Ken ;

Fujioka, Daisuke ;

Saito, Yukio ;

Kawabata, Ken-ichi ;

Obata, Jyun-ei ;

Mende, Akira ;

Kobayashi, Tsuyoshi ;

Kugiyama, Kiyotaka .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :43-50

[4]

Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy （REVERSAL） Trial[J] . Paul Schoenhagen,E Murat Tuzcu,Carolyn Apperson-Hansen,Chaohui Wang,Kathy Wolski,Songhua Lin,Ilke Sipahi,Stephen J. Nicholls,William A. Magyar,Aaron Loyd,Tammy Churchill,Tim Crowe,Steven E. Nissen.Circulation . 2006 (24)

[5]

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: Results of a randomized, double-blind, placebo-controlled study[J] . Stella M. Macin,Eduardo R. Perna,Eduardo F. Farías,Valeria Franciosi,Jorge R. Cialzeta,Mónica Brizuela,Fernanda Medina,Carlos Tajer,Hernan Doval,Reynaldo Badaracco.American Heart Journal . 2005 (3)

[6]

Trial of Atorvastatin in Rheumatoid Arthritis （TARA）: double-blind, randomised placebo-controlled trial[J] . David W McCarey,Iain B McInnes,Rajan Madhok,Rosie Hampson,Olga Scherbakova,Ian Ford,Hilary A Capell,Naveed Sattar.The Lancet . 2004 (9426)

[7] Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys [J].

Williams, JK ;

Sukhova, GK ;

Herrington, DM ;

Libby, P .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (03) :684-691

← 1 →